Galegenimab (FHTR 2163) is a humanized monoclonal antibody Fab fragment targeting the HtrA1 trimer. Galegenimab is used in research on age-related macular degeneration (AMD)[1][2].
Molecular Weight:
(47.71 kDa)
Purity:
99.91
CAS Number:
[2403683-24-7]
Target:
Ser/Thr Protease
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted